Source - SMW
Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 2500p (from 2990p).

Related Charts

Hikma Pharmaceuticals (HIK)

-21.00p (-1.09%)
delayed 18:15PM